Bright Minds Biosciences DRUG
NASDAQ DRUG
$23.45 +0.84 (+3.72%)
At close: Nov 11, 2026 · 4:00 PM EST

Bright Minds Biosciences (DRUG) Other Operating Expenses (2020 - 2026)

Updated

Bright Minds Biosciences (DRUG) recorded Other Operating Expenses of $456,707 in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 404.5% from $90,529 a year earlier and up 122.4% from the prior quarter.

Analysis

Bright Minds Biosciences (DRUG) Other Operating Expenses (2020 - 2026) Analysis & Trends

On a TTM basis, Bright Minds Biosciences' Other Operating Expenses came in at $1.01 million as of Jun 30, 2026, up 91.4% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $529,006, up 31.4% from FY2024.

  • Annual Other Operating Expenses has a five-year compound annual growth rate of -90.7% (FY2020 to FY2025).
  • Across earlier fiscal years, Other Operating Expenses came in at $402,718 in FY2024 (+24.1%), $324,622 in FY2023 (-100.0%), $509.31 billion in FY2022 (-9.3%) and $561.74 billion in FY2021 (+624.3%).
  • The fiscal Q3 2026 figure is the highest quarterly Other Operating Expenses since fiscal Q4 2022.
  • On a year-over-year basis, Other Operating Expenses has increased for three consecutive quarters, with growth averaging 64.7% over the last eight quarters.
  • Peak year-over-year performance for Other Operating Expenses in the last five years was growth of 620.9% in fiscal Q4 2021, against a decline of 100.0% in fiscal Q4 2023 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $205,330 (Q2 2026), $259,957 (Q1 2026) and $92,913 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Bright Minds Biosciences 172.65 Mn -390.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20,126.96
Mar 31, 2026 30,978.85
Dec 31, 2025 110,585.46
Sep 30, 2025 90,053.33
Jun 30, 2025 9,035.84
Mar 31, 2025 78,639.36
Dec 31, 2024 27,456.39
Sep 30, 2024 17,771.41
Jun 30, 2024 8,307.95
Mar 31, 2024 66,261.06
Dec 31, 2023 53,101.78
Sep 30, 2023 139,228.67
Jun 30, 2023 12,794.16
Mar 31, 2023 68,856.86
Dec 31, 2022 30,148.83
Sep 30, 2022 186.38 Bn
Jun 30, 2022 6,282.57
Mar 31, 2022 73,823.06
Dec 31, 2021 81,269.35
Sep 30, 2021 144.38 Bn
API Access

Bright Minds Biosciences Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=DRUG&period=max&api_key=YOUR_API_KEY